PFSA - רווח נקי למניה (EPS TTM) Profusa, Inc.

Profusa Inc (PFSA) develops unique biosensors made of "smart hydrogel" for tissue oxygen monitoring, establishing a patent barrier. This chart from the GURU.Markets platform illustrates annual net income per share, where the current metric is -6315.12. A team of top-tier engineers is driven by the scientific significance of the projects. The company is currently undergoing clinical trials, which is temporarily increasing development costs.

Business creditworthiness is determined by the ability to generate real income per share of ownership. This indicator is calculated as the ratio of total annual net profit to the number of shares, measuring the actual efficiency of capital. For Profusa Inc (PFSA), this result directly depends on the cost of high-tech biosensor distribution. Optimizing medical logistics increases profitability. By analyzing the rolling 12-month EPS, an investor assesses the sustainability of this operating model.